Global CRISPR Technology Market (2020 to 2025) - Growth, Trends, and Forecasts -

DUBLIN--()--The "CRISPR Technology Market - Growth, Trends, and Forecasts (2020 - 2025)" report has been added to's offering.

Global CRISPR Technology market is expected to witness a CAGR of 24.3% during the forecast period. Certain factors that are driving the market growth include increasing government and private funding, rising demand and adoption of crispr, technological advancements.

Companies Mentioned

  • Agilent Technologies
  • Cellecta, Inc.
  • GeneCopoeia, Inc.
  • GenScript
  • Horizon Discovery Group
  • Integrated DNA Technologies (IDT)
  • Merck KGaA
  • New England Biolabs
  • Origene Technologies, Inc.
  • Thermo Fisher Scientific

Key Market Trends

Biomedical is Expected to Hold Significant Market Share in the Application Segment

At present, the CRISPR (clustered regularly interspaced short palindromic repeat) restoration system is undeniably considered as one of the most suitable as well as promising options for genome editing. As compared to previous systems, CRISPR has more potentials and applications. Among all these, one important application is the use of CRISPR in understanding various genetic and epigenetic diseases including cancer. Study of cancer by the CRISPR system is mostly done by two approaches i.e. turning on the tumour suppressor genes and turning off the oncogenes.

As per the exact capability of CRISPR, this system can also be utilized to create specific mutations in different cell lines in order to model the cancers. This type of modeling can result in a better understanding of a variety of diseases such as cancer and the ability to further develop effective drugs.

North America Dominates the Market and Expected to do Same in the Forecast Period

The region, especially the United States, has always been a pioneer in the field of genome editing, mostly due to the favorable government initiatives and increase in funding. The first ever US trial of CRISPR in humans has begun in April 2019. Two patients are presently being treated as part of a study being conducted by University of Pennsylvania. According to NPR (National Public Radio, America), both have certain forms of cancer which are difficult to treat and both have relapsed after standard treatments. As part of the trial, researchers are taking immune cells from the patients' bodies and then are editing them with CRISPR before again putting them back in. Such novel researches are expected to drive the overall market growth throughout the region.

Key Topics Covered:


1.1 Study Deliverables

1.2 Study Assumptions

1.3 Scope of the Study




4.1 Market Overview

4.2 Market Drivers

4.2.1 Increasing Government and Private Funding

4.2.2 Rising Demand and Adoption of CRISPR

4.2.3 Technological Advancements

4.3 Market Restraints

4.3.1 High Costs of Using CRISPR

4.3.2 Ethical Concerns Related to Genetic Research

4.4 Porter's Five Force Analysis

4.4.1 Threat of New Entrants

4.4.2 Bargaining Power of Buyers/Consumers

4.4.3 Bargaining Power of Suppliers

4.4.4 Threat of Substitute Products

4.4.5 Intensity of Competitive Rivalry


5.1 Product

5.1.1 Enzymes

5.1.2 Kits & Reagents

5.1.3 Guide RNA

5.1.4 Others

5.2 Application

5.2.1 Biomedical

5.2.2 Agricultural

5.2.3 Industrial

5.2.4 Others

5.3 End User

5.3.1 Pharmaceutical companies and Biotechnology Companies

5.3.2 Academics and Government Research Institutes

5.3.3 Others (CROs etc.)

5.4 Geography

5.4.1 North America United States Canada Mexico

5.4.2 Europe Germany United Kingdom France Italy Spain Rest of Europe

5.4.3 Asia Pacific China Japan India Australia South Korea Rest of Asia-Pacific

5.4.4 Middle East and Africa GCC South Africa Rest of Middle East and Africa

5.4.5 South America Brazil Argentina Rest of South America


6.1 Company Profiles


For more information about this report visit

Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900